Clin2
NCT03000244Possibly a fitRecruiting

Long-term follow-up after stem cell or gene therapy

Cellular Immunotherapy, AdoptiveGenetic TherapyTissue DonorsHematopoietic Stem Cell Transplantation

Part of Blood & lymphatic, Genetic & congenital, Immune system & allergy clinical trials.

This study checks how people do long-term after stem cell transplant, cellular therapy, or gene therapy. It may help doctors track longer-term health effects and recovery and improve future care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2,000 people
Ages
4 years to 120 years
Study type
Observational

Who can take part

  • You are 1 year or more past stem cell transplant, cellular therapy, or gene therapy
  • You are at least 4 years old (or your child is)
  • You (or a legally authorized representative) can understand the study and sign consent
  • You have a main doctor in the US to provide ongoing care during the study
  • You do not currently have active disease relapse or a new blood cancer after treatment

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT00106925Recruiting
Long-term follow-up for people after stem cell transplant

This study follows people who are at least 3 years out from their first stem cell transplant to learn how they are doing long term. It may help improve future transplant care by tracking outcomes over time.

Bethesda, Maryland
NCT06856226Recruiting
Drug metabolism study for stem cell transplant patients

This study looks at how your body processes medications after a stem cell transplant from a donor. It aims to find the best way to test your genes to improve future treatments.

Bethesda, Maryland
NCT05529342Enrolling by invitation
Long-term follow-up for a prior gene-cell treatment

This study follows people long-term after receiving a specific gene-cell treatment called AGT103-T. It helps researchers check long-term safety and outcomes, which can guide future care for others.

Washington D.C., District of Columbia
NCT05472649Enrolling by invitation
Long-term follow-up after gene-modified cell therapy

This study checks your health over time after you previously received gene-modified cell therapy in a Sorrento-sponsored trial. It helps researchers understand long-term safety and outcomes and may lead to better care for future patients.

Philadelphia, Pennsylvania
NCT02315599Enrolling by invitation
Follow-up for delayed side effects after gene-cell therapy

This study checks people for delayed side effects after receiving gene-based cell therapy from the NIH. It helps doctors learn what problems may happen later and how to monitor them safely.

Bethesda, Maryland
NCT01629017Recruiting
Long-term follow-up after a stem cell transplant

This study looks at the long-term health effects of hematopoietic (blood-forming) stem cell transplants. It may help doctors better understand and manage late side effects for children and teens after transplant.

Stanford, California

Hear when a new Hematopoietic Stem Cell Transplantation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.